Baby Formula Makers Abbott and Reckitt See Stocks Slide

Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
A St. Louis judge has granted a motion for a new trial in a case Abbott Laboratories won in the fall, in which a mother alleged that the company’s cow’s milk-based products for premature infants contributed to her son’s severe illness — a setback for Abbott,
That baby formula trial Abbott and Reckitt had won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Is Abbott Laboratories (ABT) the Best Healthcare Stock For Long-Term Investment?
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
Abbott’s Whitfield case re-trial granted, not overturned, says BofA
Abbott (ABT) in October 2024 won the Whitfield case, though the plaintiffs appealed the Whitfield verdict and on Thursday, the judge granted a ...
Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's second consecutive day of losses.
The Citizen10h
Abbott sends film crew to highlight partnership with Auburn Community Hospital
Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...
Abbott Laboratories stock underperforms Tuesday when compared to competitors
Shares of Abbott Laboratories ABT slid 3.42% to $132.66 Tuesday, on what proved to be an all-around rough trading session for ...
Abbott Labs sued for alleged ADA, human rights and whistleblower protection violations
Two former employees say the Scarborough plant failed to accommodate their disabilities and created a hostile work ...
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. If we consider the ...